Endothelial dysfunction and coronary atherosclerosis

Area of Science:

• Cardiovascular Biology
• Endothelial Cell Function
• Atherosclerosis Pathogenesis

Background:

• Endothelial cells are crucial in atherosclerosis development and progression.
• Endothelial dysfunction disrupts the balance of vasoconstrictive and vasodilatory factors, notably nitric oxide (NO) and angiotensin II.
• This imbalance impacts endothelial functions critical to atherosclerosis.

Purpose of the Study:

• To elucidate the roles of NO and angiotensin II in the pathogenesis of atherosclerosis.
• To highlight how endothelial dysfunction contributes to atherosclerotic lesion development.

Main Methods:

• Review of existing evidence on endothelial cell function in atherosclerosis.
• Focus on the specific roles of NO and angiotensin II signaling pathways.
• Analysis of how endothelial dysfunction influences molecular mediators of atherosclerosis.

Main Results:

• Endothelial dysfunction leads to decreased NO bioactivity and increased angiotensin II.
• This imbalance elevates oxidative stress and the expression of adhesion molecules, cytokines, and chemokines.
• These molecular changes promote inflammation, proliferation, and thrombogenesis, driving atherosclerotic lesions.

Conclusions:

• NO and angiotensin II are key players in atherosclerosis pathogenesis.
• Therapies improving endothelial function, like statins and ACE inhibitors, reduce cardiovascular events.
• Targeting endothelial dysfunction offers a promising therapeutic strategy for atherosclerosis.